{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:54:15Z","timestamp":1785153255584,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ygyno.2021.12.020","type":"journal-article","created":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T17:51:39Z","timestamp":1640800299000},"page":"543-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Assessment of recurrence rate and risk factors of relapse in stage in IA vulvar carcinoma"],"prefix":"10.1016","volume":"164","author":[{"given":"Julie L.","family":"Schleiss-Andreassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligita Paskeviciute","family":"Fr\u00f8ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estrid","family":"St\u00e6hr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"H\u00f8gdall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Pernille","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estrid","family":"H\u00f8gdall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine Henrichsen","family":"Schnack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.12.020_bb0005","series-title":"National \u00c5rsrapport 2017\/2018 og 2018\/2019 DGCD: DGCG","year":"2017"},{"issue":"Suppl. 2","key":"10.1016\/j.ygyno.2021.12.020_bb0010","first-page":"S76","article-title":"Cancer of the vulva","volume":"131","author":"Hacker","year":"2015","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0015","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1185\/03007995.2016.1162147","article-title":"The prognostic role of FIGO stage in patients with vulvar cancer: a systematic review and meta-analysis","volume":"32","author":"Zhou","year":"2016","journal-title":"Curr. Med. Res. Opin."},{"issue":"1","key":"10.1016\/j.ygyno.2021.12.020_bb0020","first-page":"7","article-title":"Cancer Statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.1016\/j.ygyno.2021.12.020_bb0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijgo.2009.02.009","article-title":"Revised FIGO staging for carcinoma of the cervix","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0030","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijgo.2009.02.011","article-title":"Revised FIGO staging for carcinoma of the vulva","volume":"105","author":"Hacker","year":"2009","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0035","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/ijgc-2018-000046","article-title":"Superficially invasive stage IA vulvar squamous cell carcinoma-therapy and prognosis","volume":"29","author":"Grimm","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2021.12.020_bb0040","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1525-1438.2007.00873.x","article-title":"Lymph node recurrence following stage IA vulvar carcinoma: two cases and a short overview of literature","volume":"17","author":"Vernooij","year":"2007","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2021.12.020_bb0045","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ygyno.2006.10.004","article-title":"Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis","volume":"104","author":"Chan","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0050","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ygyno.2016.06.019","article-title":"Adjacent lichen sclerosis predicts local recurrence and second field tumour in women with vulvar squamous cell carcinoma","volume":"142","author":"Yap","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0055","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/PAS.0b013e318159a2cb","article-title":"Stage IA vulvar squamous cell carcinoma: an analysis of tumor invasive characteristics and risk","volume":"32","author":"Yoder","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0060","series-title":"Female Genital Tumours","author":"Board WCoTE","year":"2020"},{"key":"10.1016\/j.ygyno.2021.12.020_bb0065","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/01.AOG.0000187301.76283.7f","article-title":"Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women","volume":"106","author":"Jones","year":"2005","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0070","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1006\/gyno.2000.5882","article-title":"Squamous vulvar cancer: a clinically based individualization of treatment","volume":"78","author":"Rodolakis","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0085","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.bpobgyn.2014.07.010","article-title":"Vulvar intraepithelial neoplasia","volume":"28","author":"Preti","year":"2014","journal-title":"Best Pract. Res. Clin. Obstet Gynaecol."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0090","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/IGC.0000000000000975","article-title":"European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer.","volume":"4","author":"oonk","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2021.12.020_bb0095","series-title":"Retningslinier for visitation, diagnostik, behandling og kontrol af vulvacancer","year":"2012"},{"key":"10.1016\/j.ygyno.2021.12.020_bb0100","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1471-0528.1998.tb10053.x","article-title":"The management of squamous cell vulval cancer: a population based retrospective study of 411 cases","volume":"105","author":"Rhodes","year":"1998","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0105","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2147\/CLEP.S99479","article-title":"Danish gynecological cancer database","volume":"8","author":"Sorensen","year":"2016","journal-title":"Clin Epidemiol."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0115","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.bpobgyn.2015.01.004","article-title":"Staging for vulvar cancer","volume":"29","author":"Hacker","year":"2015","journal-title":"Best Pract. Res. Clin. Obstet Gynaecol."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0120","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/gyno.1999.5638","article-title":"Squamous cell carcinoma of the vulva stage IA: long-term results","volume":"76","author":"Magrina","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.hoc.2011.10.006","article-title":"Current management of vulvar cancer","volume":"26","author":"Fuh","year":"2012","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0130","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1097\/PAS.0b013e31829f306a","article-title":"Interobserver agreement for assessing invasion in stage 1A vulvar squamous cell carcinoma","volume":"37","author":"Abdel-Mesih","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0135","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/his.13883","article-title":"Measuring the depth of invasion in vulvar squamous cell carcinoma: interobserver agreement and pitfalls","volume":"75","author":"Pouwer","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2021.12.020_bb0140","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ygyno.2017.11.006","article-title":"Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: a systematic review","volume":"148","author":"Te Grootenhuis","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ygyno.2012.06.005","article-title":"Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distribution","volume":"127","author":"Tabbaa","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0150","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/0002-9378(91)90573-A","article-title":"Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study)","volume":"164","author":"Homesley","year":"1991","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jnci.2013.05.001","article-title":"Groin recurrence in patients with early vulvar cancer following superficial inguinal node dissection","volume":"25","author":"El Afandy","year":"2013","journal-title":"J. Egypt Natl. Canc. Inst."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0160","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ygyno.2019.05.010","article-title":"Margin status revisited in vulvar squamous cell carcinoma","volume":"154","author":"Te Grootenhuis","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0165","doi-asserted-by":"crossref","first-page":"768","DOI":"10.5858\/arpa.2018-0019-RS","article-title":"Differentiated vulvar intraepithelial neoplasia: a brief review of clinicopathologic features","volume":"143","author":"Jin","year":"2019","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0170","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00428-018-2436-8","article-title":"Differentiated vulvar intraepithelial neoplasia (dVIN): the most helpful histological features and the utility of cytokeratins 13 and 17","volume":"473","author":"Dasgupta","year":"2018","journal-title":"Virchows Arch."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0175","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/ijc.31139","article-title":"Does HPV status influence survival after vulvar cancer?","volume":"142","author":"Rasmussen","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.12.020_bb0180","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ygyno.2003.11.052","article-title":"Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma","volume":"92","author":"Pinto","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0185","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ygyno.2011.05.016","article-title":"Does human papillomavirus infection imply a different prognosis in vulvar squamous cell carcinoma?","volume":"122","author":"Alonso","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.12.020_bb0190","article-title":"Prevalence of human papillomavirus and its prognostic value in vulvar cancer: a systematic review and meta-analysis","volume":"13","author":"Zhang","year":"2018","journal-title":"PLoS One"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821016796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821016796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:00:20Z","timestamp":1758772820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821016796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0090825821016796"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.12.020","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of recurrence rate and risk factors of relapse in stage in IA vulvar carcinoma","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}